Please use this identifier to cite or link to this item:
Title: Management of chronic hepatitis B and C virus infections.
Authors: Chongsrisawat, Voranush
Poovorawan, Yong
Issue Date: 4-Feb-2002
Citation: Chongsrisawat V, Poovorawan Y. Management of chronic hepatitis B and C virus infections. Indian Journal of Pediatrics. 2002 Feb; 69(2): 149-54
Abstract: Hepatitis B and C virus (HBV and HCV) infections present an important health problem causing significant morbidity and mortality on a worldwide scale. The younger the subjects infected, the higher the risk predisposing to progression towards chronic infection. Treatment of chronic HBV and HCV infections is aimed at reducing hepatic inflammation and thus improving the symptoms, decreasing the likelihood of long-term sequelae such as hepatocellular carcinoma, and increasing the survival rate. Interferon accelerates the spontaneous course of chronic HBV infection in children with greater disease activity and lower levels of replication. There is limited information on the use of lamivudine and its long-term benefit in children with chronic HBV infection. The response of combination therapy with IFN and ribavirin in children with chronic HCV infection is still under investigation. The long-term clinical and virological effects of various drugs used in chronic HBV and HCV infections on children remain to be evaluated.
Description: 50 references.
Appears in Collections:Indian Journal of Pediatrics

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.